+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Celiac Disease Market and Competitive Landscape - 2020

  • ID: 5023513
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Celiac Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Celiac Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Celiac Disease market size and drug sales. It also provides insights into Celiac Disease epidemiology and late stage pipeline.

This research covers the following: Celiac Disease treatment options, Celiac Disease late stage clinical trials pipeline, Celiac Disease prevalence by countries, Celiac Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Celiac Disease pipeline: Find out drugs in clinical trials for the treatment of Celiac Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Celiac Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Celiac Disease by countries
  • Celiac Disease drugs: Identify key drugs marketed and prescribed for Celiac Disease in the US, including trade name, molecule name, and company
  • Celiac Disease drugs sales: Find out the sales value for Celiac Disease drugs by countries
  • Celiac Disease market valuations: Find out the market size for Celiac Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Celiac Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Celiac Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Celiac Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Celiac Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Celiac Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Celiac Disease Treatment Options

2. Celiac Disease Pipeline Insights
2.1. Celiac Disease Phase 3 Clinical Trials
2.2. Celiac Disease Phase 2 Clinical Trials
2.3. Celiac Disease Phase 1 Clinical Trials

3. Celiac Disease Epidemiology Analysis by Countries

4. Germany Celiac Disease Market Insights
4.1. Marketed Drugs for Celiac Disease in Germany
4.2. Germany Celiac Disease Market Size & Forecast
4.3. Germany Celiac Disease Drugs Sales Forecast
4.4. Germany Celiac Disease Market Share Analysis

5. France Celiac Disease Market Insights
5.1. Marketed Drugs for Celiac Disease in France
5.2. France Celiac Disease Market Size & Forecast
5.3. France Celiac Disease Product Sales Forecast
5.4. France Celiac Disease Market Share Analysis

6. Italy Celiac Disease Market Insights
6.1. Marketed Drugs for Celiac Disease in Italy
6.2. Italy Celiac Disease Market Size & Forecast
6.3. Italy Celiac Disease Product Sales Forecast
6.4. Italy Celiac Disease Market Share Analysis

7. Spain Celiac Disease Market Insights
7.1. Marketed Drugs for Celiac Disease in Spain
7.2. Spain Celiac Disease Market Size & Forecast
7.3. Spain Celiac Disease Product Sales Forecast
7.4. Spain Celiac Disease Market Share Analysis

8. UK Celiac Disease Market Insights
8.1. Marketed Drugs for Celiac Disease in UK
8.2. UK Celiac Disease Market Size & Forecast
8.3. UK Celiac Disease Product Sales Forecast
8.4. UK Celiac Disease Market Share Analysis

9. Europe Celiac Disease Market Insights
9.1. Europe Celiac Disease Market Size & Forecast
9.2. Europe Celiac Disease Product Sales Forecast
9.3. Europe Celiac Disease Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Celiac Disease Phase 3 Clinical Trials, Global, 2020
Table 2: Celiac Disease Phase 2 Clinical Trials, Global, 2020
Table 3: Celiac Disease Phase 1 Clinical Trials, Global, 2020
Table 4: Celiac Disease Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Celiac Disease in Germany, 2019
Table 6: Germany Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Celiac Disease Product Sales ($mn), 2016 - 2024
Table 8: Germany Celiac Disease Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Celiac Disease in France, 2019
Table 10: France Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Celiac Disease Product Sales ($mn), 2016 - 2024
Table 12: France Celiac Disease Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Celiac Disease in Italy, 2019
Table 14: Italy Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Celiac Disease Product Sales ($mn), 2016 - 2024
Table 16: Italy Celiac Disease Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Celiac Disease in Spain, 2019
Table 18: Spain Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Celiac Disease Product Sales ($mn), 2016 - 2024
Table 20: Spain Celiac Disease Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Celiac Disease in UK, 2019
Table 22: UK Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Celiac Disease Product Sales ($mn), 2016 - 2024
Table 24: UK Celiac Disease Market Events and Trends, 2016 - 2024
Table 25: Europe Celiac Disease Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Celiac Disease Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Celiac Disease Pipeline by Phase (%), Global, 2020
Figure 2: Celiac Disease Prevalence by Countries, 2016 - 2024
Figure 3: Germany Celiac Disease Market Size ($mn), 2016 - 2024
Figure 4: Germany Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 5: Germany Celiac Disease Market Share by Drugs (%), 2019
Figure 6: Germany Celiac Disease Market - Future Market Share (%), 2024
Figure 7: France Celiac Disease Market Size ($mn), 2016 - 2024
Figure 8: France Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 9: France Celiac Disease Market Share by Drugs (%), 2019
Figure 10: France Celiac Disease Market - Future Market Share (%), 2024
Figure 11: Italy Celiac Disease Market Size ($mn), 2016 - 2024
Figure 12: Italy Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 13: Italy Celiac Disease Market Share by Drugs (%), 2019
Figure 14: Italy Celiac Disease Market - Future Market Share (%), 2024
Figure 15: Spain Celiac Disease Market Size ($mn), 2016 - 2024
Figure 16: Spain Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 17: Spain Celiac Disease Market Share by Drugs (%), 2019
Figure 18: Spain Celiac Disease Market - Future Market Share (%), 2024
Figure 19: UK Celiac Disease Market Size ($mn), 2016 - 2024
Figure 20: UK Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 21: UK Celiac Disease Market Share by Drugs (%), 2019
Figure 22: UK Celiac Disease Market - Future Market Share (%), 2024
Figure 23: Europe Celiac Disease Market Size ($mn), 2016 - 2024
Figure 24: Europe Celiac Disease Product Sales ($mn), 2016 - 2024
Figure 25: Europe Celiac Disease Market Share by Drugs (%), 2019
Figure 26: Europe Celiac Disease Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll